China vs Sudan: The number of people with susceptibility test result for rifampicin
China
79.92
in 2021
Sudan
79.91
in 2021
China rank
95th
Sudan rank
96th
The number of people with susceptibility test result for rifampicin over time
- China
- Sudan
How they compare
China currently reports 79.92 against 79.91 in Sudan, a difference of 0.01.
Across all 5 years both countries report, China has been ahead every year.
China ranks 95th and Sudan ranks 96th of 146 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.88 | 24.99 | 34.89 | China |
| 2020s | 81.69 | 72.49 | 9.2 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, China or Sudan?
- China, at 79.92 against 79.91 in Sudan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between China and Sudan?
- 0.01, with China ahead.
- How many years of comparable data are there for China and Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do China and Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- China ranks 95th and Sudan ranks 96th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.